Mediwound completes patient enrollment for interim assessment of its u.s. escharex phase 2 adaptive design study

Interim assessment expected by end of july 2021 and completion of enrollment by year-end 2021 interim assessment expected by end of july 2021 and completion of enrollment by year-end 2021
MDWD Ratings Summary
MDWD Quant Ranking